Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Spanish biotech firm Biofabri has announced promising early-stage results for ENCORE-01, a novel immunotherapy candidate targeting muscle-invasive bladder cancer (MIBC). In a multicenter trial across 15 Spanish hospitals, the treatment ... Read More
Continuous Coverage
Irish Foreign Minister Micheál Martin condemned Israel’s handling of detainees, including Irish citizen Catriona Graham, after a video…
Hollywood’s latest blockbuster isn’t a movie—it’s a reckoning. As plastic waste and air pollution push endangered species toward…
NASCAR’s 2026 season just hit a defining moment as the sport’s most volatile driver, Bubba Wallace, delivered a…
InfoTrack, a Sydney-based fintech infrastructure provider, and the Chartered Accountants Australia & New Zealand (CA ANZ) are integrating…
Skyworks Solutions (NASDAQ: SWKS) has launched exchange offers and consent solicitations for Qorvo’s (NASDAQ: QRVO) senior notes due…
The winning ticket—crumpled, slightly damp from the humid Bataan breeze—was tucked into a plastic bag inside a sari-sari…
Global Affairs
Former U.S. President Donald Trump’s latest diplomatic gambit—placing Iran nuclear negotiations in their “final stage” while signaling a…
Markets And Money
More than 60% of microenterprises in Antioquia, Colombia’s economic powerhouse, generate less than $3 million monthly—an average revenue…
Digital Culture
As of mid-2026, Samsung’s Galaxy Z Flip series—once the poster child for foldable smartphones—has vanished from public roadmaps,…
Science And Wellbeing
In this week’s Journal of the American Medical Association (JAMA), researchers exposed a critical flaw in how Alzheimer’s…
Screen And Sound
New Zealand’s job market is quietly becoming a testing ground for AI’s next frontier: not just replacing roles,…
Fixtures And Form
The NRL’s salary cap earthquake has struck early in 2026, as the Dolphins’ star outside back Jordan Farnworth…
